BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6433356)

  • 1. Intravesical chemotherapy in the management of superficial bladder tumors.
    Schulman CC
    Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for intensive intravesical chemotherapy.
    Soloway MS
    Prog Clin Biol Res; 1984; 153():287-95. PubMed ID: 6433357
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intravesical chemotherapy in superficial tumors of the bladder].
    Schulman CC
    Arch Esp Urol; 1983; 36(1):32-40. PubMed ID: 6409013
    [No Abstract]   [Full Text] [Related]  

  • 4. Surgery and intravesical chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    Soloway MS
    J Urol; 1980 Apr; 123(4):461-6. PubMed ID: 6767860
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravesical chemotherapy of superficial bladder cancer.
    Lum BL
    Recent Results Cancer Res; 1983; 85():3-36. PubMed ID: 6408716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in the internist treatment of bladder tumors].
    Baumgartner G
    Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical therapy for bladder cancer.
    Soloway MS
    Urol Clin North Am; 1988 Nov; 15(4):661-9. PubMed ID: 3142129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.
    Boccon-Gibod L
    Prog Clin Biol Res; 1992; 378():55-7. PubMed ID: 1301586
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravesical chemotherapy.
    Prout GR
    Prog Clin Biol Res; 1984; 162B():125-50. PubMed ID: 6438639
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical chemotherapy--frequency of instillation.
    Smith PH
    Prog Clin Biol Res; 1985; 185B():57-68. PubMed ID: 3929271
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic agents: intravesical instillation.
    Brixey MT
    Urol Nurs; 1988; 9(2):4-6. PubMed ID: 3145560
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP
    Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract]   [Full Text] [Related]  

  • 18. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.